Literature DB >> 74245

Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.

C Chany, I Cerutti.   

Abstract

The antiviral effect of interferon against encephalomyocarditis (EMC) virus infection in mice was enhanced by isoprinosine. However, the enhancement was only obtained when both interferon and the virus were inoculated into the peritoneum; the inoculation route of isoprinosone did not modify significantly the final results. In addition, the time sequence of injections was of great importance; generally the injection of isoprinosine had to precede that of interferon by a few hours.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 74245     DOI： 10.1007/BF01319908

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  14 in total

1.  Inhibition of interferon action by cytochalasin B, colchicine, and vinblastine.

Authors:  M F Bourgeade; C Chany
Journal:  Proc Soc Exp Biol Med       Date:  1976-12

2.  Specificity and reversibility of interferon ganglioside interaction.

Authors:  F Besancon; H Ankel; S Basu
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

Review 3.  Membrane-bound interferon specific cell receptor system: role in the establishment and amplification of the antiviral state.

Authors:  C Chany
Journal:  Biomedicine       Date:  1976-06

4.  Origin and possible mode of action of a tissue antagonist of interferon.

Authors:  F Fournier; C Chany; M Sarragne
Journal:  Nat New Biol       Date:  1972-01-12

5.  Binding of interferon to gangliosides.

Authors:  F Besancon; H Ankel
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

6.  Mode of action and biological properties of insoluble interferon.

Authors:  C Chany; H Ankel; B Galliot; M J Chevalier; A Gregoire
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

7.  Effect of repeated inoculation of interferon preparations on infection of mice with encephalomyocarditis virus.

Authors:  I Gresser; C Bourali; M T Thomas; E Falcoff
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

8.  A method for the large scale production of potent interferon preparations.

Authors:  M G Tovey; J Begon-Lours; I Gresser
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

9.  [Inhibition of interferon action by glycoprotein hormones].

Authors:  F Besançon; H Ankel
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1976-12-20

10.  Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity.

Authors:  L D Kohn; R M Friedman; J M Holmes; G Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205
View more
  7 in total

1.  Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.

Authors:  A Muñoz; R A García; A Pérez-Aranda
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Coordinated therapeutic effects of immune modulators and interferon.

Authors:  I Cerutti; C Chany
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

3.  Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.

Authors:  D Sergiescu; I Cerutti; A Kahan; D Piatier; E Efthymiou
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

Review 4.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

5.  Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.

Authors:  J Imanishi; M Matsubara; C J Won; H Nomura; T Kishida
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 6.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

Review 7.  Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.

Authors:  Seidu A Richard; Sylvanus Kampo; Maite Esquijarosa Hechavarria; Marian Sackey; Alexis D B Buunaaim; Eugene Dogkotenge Kuugbee; Thomas Winsum Anabah
Journal:  J Immunol Res       Date:  2020-09-25       Impact factor: 4.818
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.